A drug used to treat rheumatoid arthritis has been found to improve survival of hospitalized Covid-19 patients.
The discovery comes from a study of over 1,500 Covid-19 patients in 12 countries and is being hailed as a significant breakthrough for treatment options for people who are severely ill with Covid-19.
An initial study on just 15 moderately and severely ill Covid-19 patients showed that 11 of them did better than expected when treated with baricitinib, so the researchers designed a large study of over 1,500 patients to test the therapy further.
The researchers found that baricitinib reduced deaths by 5%, saving 1 in 20 patients who would otherwise have died from Covid-19 within 60 days.
Crucially, the patients who benefitted the most from the drug were the most severely ill, including those on a bipap machine to help them breathe or high flow oxygen.
In these more severely ill patients, the researchers found that 1 in 9 patients were saved who would have otherwise died.
MORE FOR YOU. "It is increasingly evident that treatment with baricitinib may help prevent death in some of the most critically ill COVID-19 patients, and that this class of medications represents an important treatment advance for this vulnerable group of patients in the constantly evolving pandemic," said Ely.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Saturday, September 4, 2021
Arthritis Drug 'Will Save Thousands' Of Covid-19 Patients After Excellent Trial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment